MEGAN HOLICK: Open Payments
NPI 1346754199 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,178 in 105 payments from 16 companies in 2025. Trend: 2023 $2,528 · 2024 $3,234 · 2025 $2,178
Food & beverage: $2,096Education: $82
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $480 |
| Novartis Pharmaceuticals Corporation | 20 | $322 |
| Janssen Biotech, Inc. | 7 | $215 |
| UCB, Inc. | 9 | $210 |
| E.R. Squibb & Sons, L.L.C. | 15 | $185 |
| Incyte Corporation | 4 | $162 |
| Lilly USA, LLC | 4 | $144 |
| Regeneron Healthcare Solutions, Inc. | 2 | $111 |
| LEO Pharma Inc. | 2 | $99 |
| Amgen Inc. | 4 | $72 |
Products named: SKYRIZI, RINVOQ, TREMFYA, Bimzelx, Sotyktu, OPZELURA, DUPIXENT, COSENTYX.
Industry payments across KS — which companies pay providers there.
